Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Mycobacterium szulgai

Introduction

Overview

Overview

Mycobacterium szulgai is a species of Mycobacterium. It is a Scotochromogen and is currently ungrouped. It is known to cause skin infections.[1]

Treatment

Treatment

Antimicrobial Regimen

  • 1. in vitro susceptibility
  • M. szulgai is susceptible in vitro to most antituberculous drugs including Quinolones and newer Macrolides
  • 2. Infection
  • 2.1 Pulmonary infection
  • Three- or four-drug regimen based on susceptibility that includes 12 months of negative sputum cultures while on therapy
  • 2.2 Extrapulmonary infection
  • Combination anti-tuberculous medications based on in vitro susceptibilities for 4-6 months
References

References

  1. ↑ Hizawa K, Nagata Y, Kudo T, Taniguchi M, Matsumoto T, Iida M (September 2009). “[A case of steroid-dependent ulcerative colitis complicated by skin infection of Mycobacterium szulgai]”. Nippon Shokakibyo Gakkai Zasshi (in Japanese). 106 (9): 1359–63. PMID 19734708.
  2. ↑ Griffith, David E.; Aksamit, Timothy; Brown-Elliott, Barbara A.; Catanzaro, Antonino; Daley, Charles; Gordin, Fred; Holland, Steven M.; Horsburgh, Robert; Huitt, Gwen; Iademarco, Michael F.; Iseman, Michael; Olivier, Kenneth; Ruoss, Stephen; von Reyn, C. Fordham; Wallace, Richard J.; Winthrop, Kevin; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America (2007-02-15). “An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases”. American Journal of Respiratory and Critical Care Medicine. 175 (4): 367–416. doi:10.1164/rccm.200604-571ST. ISSN 1073-449X. PMID 17277290.
  3. ↑ Tortoli, E.; Besozzi, G.; Lacchini, C.; Penati, V.; Simonetti, M. T.; Emler, S. (1998-04). “Pulmonary infection due to Mycobacterium szulgai, case report and review of the literature”. The European Respiratory Journal. 11 (4): 975–977. ISSN 0903-1936. PMID 9623706. Check date values in: |date= (help)

Editor-In-Chief: Template:Seealso C. Michael Gibson, M.S., M.D. [1]